{"type":"PR","pr":{"number":72,"head":"2e78339b1e7665391c2c6d0dc869be3809e8a168"},"user":"silvia.vernotico","status":"draft","branch":"cms/2018-09-09-hot-this-week-in-farmaceutica-younger-n-66","collection":"hotthisweek","title":"HOT THIS WEEK IN FARMACEUTICA YOUNGER N.66","description":"Sanofi ha ottenuto dalla Commissione europea l’ok per l’autorizzazione all’immissione in commercio di caplacizumab (ALX-0081), prima terapia specifica per il trattamento della aTTP (porpora trombotica trombocitopenica acquisita).","objects":{"entry":{"path":"site/content/hotthisweek/2018-09-09-hot-this-week-in-farmaceutica-younger-n-66.md","sha":"0e102a5d36adba0bd6112a84663dae37b880f23b"},"files":[{"path":"/site/static/img/img_4376.jpg","sha":"e706df0480cd66bbc924e1de6ba3e2c8dd3ffe53"},{"path":"/site/static/img/img_4376.jpg","sha":"e706df0480cd66bbc924e1de6ba3e2c8dd3ffe53"}]},"timeStamp":"2018-11-14T11:10:09.353Z"}